cognitive

Dihexa

FDA: research-only
Last updated · 2026-04-12

Dihexa is a nootropic peptide derived from angiotensin IV that enhances synaptogenesis and supports BDNF signaling pathways. It is considered one of the most potent cognitive enhancers in the peptide space, promoting long-term synaptic connectivity critical for learning and memory. Enhances synaptogenesis (formation of new synaptic connections) and may support BDNF signaling pathways. Promotes long-term synaptic connectivity critical for learning and memory. Stimulates neurotrophic activity and neurogenesis. Supports hippocampal function and cognitive plasticity. Evidence to date is preclinical — angiotensin-IV-analog studies in rodents and cell systems showing synaptogenesis via the hepatocyte growth factor (HGF)/c-Met system; there are no human clinical

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number 1401708-83-5
Route
Where to buy Dihexa →Swiss Chems · save 10% code aewpzbzd

Stacks containing Dihexa

28-day resets featuring Dihexa

02

Sourcing

Current prices

Updated today

5mg

Only vendor stocking this size on the VialBase roster.

500mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 10% with code aewpzbzd at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

Also vetted at
What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Blood Pressure
DURING CYCLE
  • CMP
  • Blood Pressure
POST-CYCLE
  • CMP
  • Blood Pressure
Safety & Regulatory Status
FDA STATUS research-only

Regulatory status for Dihexa may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Dihexa?
Dihexa is a nootropic peptide derived from angiotensin IV that enhances synaptogenesis and supports BDNF signaling pathways. It is considered one of the most potent cognitive enhancers in the peptide space, promoting long-term synaptic connectivity critical for learning and memory.
How does Dihexa work?
Enhances synaptogenesis (formation of new synaptic connections) and may support BDNF signaling pathways. Promotes long-term synaptic connectivity critical for learning and memory. Stimulates neurotrophic activity and neurogenesis.
How is Dihexa dosed?
Oral: 4-8 mg/day (most common); 5-20 mg in research protocols; Cycle: 10 days on, 5 off; or 3-5x/week; Route: Oral (primary); SubQ also noted. These figures reflect commonly cited research protocols, not medical advice — consult a clinician.
Is Dihexa FDA-approved?
Dihexa is a research-only compound and is not FDA-approved. Research compound — not FDA-approved for human use; Not approved in any jurisdiction for clinical use; Available through research chemical suppliers.